Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 7.69669078 |
2 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 7.25385836 |
3 | thrombin receptor signaling pathway (GO:0070493) | 7.14565700 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.02073039 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.02073039 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.02073039 |
7 | modulation by symbiont of host immune response (GO:0052553) | 7.02073039 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 7.02073039 |
9 | modulation by symbiont of host defense response (GO:0052031) | 7.02073039 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.42202446 |
11 | macrophage activation involved in immune response (GO:0002281) | 6.33633898 |
12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.27190847 |
13 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.72788935 |
14 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.72788935 |
15 | response to inactivity (GO:0014854) | 5.61867228 |
16 | dendritic cell chemotaxis (GO:0002407) | 5.61445211 |
17 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.51572168 |
18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.35593021 |
19 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.27499844 |
20 | T cell migration (GO:0072678) | 5.12524761 |
21 | macrophage activation (GO:0042116) | 5.12013123 |
22 | negative regulation of bone remodeling (GO:0046851) | 4.97858471 |
23 | positive regulation of chemokine secretion (GO:0090197) | 4.97573720 |
24 | neutrophil activation involved in immune response (GO:0002283) | 4.95282984 |
25 | negative regulation of type 2 immune response (GO:0002829) | 4.91270478 |
26 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.84428490 |
27 | regulation of T cell chemotaxis (GO:0010819) | 4.82359502 |
28 | positive regulation of T cell chemotaxis (GO:0010820) | 4.82359502 |
29 | positive regulation of interferon-alpha production (GO:0032727) | 4.80138949 |
30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76015851 |
31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75451955 |
32 | regulation of cellular extravasation (GO:0002691) | 4.64178913 |
33 | regulation of interferon-alpha production (GO:0032647) | 4.54197205 |
34 | response to host immune response (GO:0052572) | 4.52637631 |
35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52637631 |
36 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.50976951 |
37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.42236106 |
38 | interkinetic nuclear migration (GO:0022027) | 4.38725250 |
39 | myeloid cell activation involved in immune response (GO:0002275) | 4.37315780 |
40 | dendritic cell migration (GO:0036336) | 4.31259849 |
41 | definitive hemopoiesis (GO:0060216) | 4.31169712 |
42 | positive regulation of antigen processing and presentation (GO:0002579) | 4.27831193 |
43 | negative regulation of tissue remodeling (GO:0034104) | 4.25477231 |
44 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.24711110 |
45 | lipoxygenase pathway (GO:0019372) | 4.24618856 |
46 | monocyte chemotaxis (GO:0002548) | 4.22144562 |
47 | regulation of chemokine secretion (GO:0090196) | 4.18189109 |
48 | pinocytosis (GO:0006907) | 4.15781427 |
49 | response to host (GO:0075136) | 4.15691070 |
50 | response to host defenses (GO:0052200) | 4.15691070 |
51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.15691070 |
52 | purinergic receptor signaling pathway (GO:0035587) | 4.11878929 |
53 | regulation of T-helper 1 type immune response (GO:0002825) | 4.10722130 |
54 | response to muramyl dipeptide (GO:0032495) | 4.05966443 |
55 | eosinophil chemotaxis (GO:0048245) | 4.02748478 |
56 | negative regulation of granulocyte differentiation (GO:0030853) | 4.00788812 |
57 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.99863308 |
58 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.94992142 |
59 | macrophage chemotaxis (GO:0048246) | 3.90844026 |
60 | response to peptidoglycan (GO:0032494) | 3.89944543 |
61 | lymphocyte chemotaxis (GO:0048247) | 3.79943520 |
62 | regulation of hypersensitivity (GO:0002883) | 3.70976131 |
63 | phagocytosis, engulfment (GO:0006911) | 3.69542617 |
64 | regulation of antigen processing and presentation (GO:0002577) | 3.68703350 |
65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66127250 |
66 | positive regulation of T cell migration (GO:2000406) | 3.65585933 |
67 | granulocyte activation (GO:0036230) | 3.62985912 |
68 | glycosphingolipid catabolic process (GO:0046479) | 3.58843174 |
69 | DNA ligation (GO:0006266) | 3.56398186 |
70 | I-kappaB phosphorylation (GO:0007252) | 3.54100751 |
71 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.50739241 |
72 | eosinophil migration (GO:0072677) | 3.50270643 |
73 | neutrophil activation (GO:0042119) | 3.49921183 |
74 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.49463254 |
75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49391153 |
76 | negative regulation of cell killing (GO:0031342) | 3.49391153 |
77 | cytidine deamination (GO:0009972) | 3.46995017 |
78 | cytidine metabolic process (GO:0046087) | 3.46995017 |
79 | cytidine catabolic process (GO:0006216) | 3.46995017 |
80 | negative regulation of mast cell activation (GO:0033004) | 3.45660772 |
81 | * cyclooxygenase pathway (GO:0019371) | 3.44693498 |
82 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40543874 |
83 | hyaluronan catabolic process (GO:0030214) | 3.38893247 |
84 | regulation of mast cell degranulation (GO:0043304) | 3.38182226 |
85 | ceramide catabolic process (GO:0046514) | 3.37483268 |
86 | cellular response to exogenous dsRNA (GO:0071360) | 3.37148546 |
87 | cardiolipin metabolic process (GO:0032048) | 3.37104631 |
88 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34524711 |
89 | sleep (GO:0030431) | 3.34124843 |
90 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.32635944 |
91 | regulation of T cell migration (GO:2000404) | 3.30456614 |
92 | positive regulation of B cell differentiation (GO:0045579) | 3.26392107 |
93 | positive regulation of interferon-beta production (GO:0032728) | 3.26227239 |
94 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24574045 |
95 | positive regulation of granulocyte differentiation (GO:0030854) | 3.22353970 |
96 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.22102012 |
97 | mature B cell differentiation involved in immune response (GO:0002313) | 3.18621357 |
98 | glycolipid catabolic process (GO:0019377) | 3.17845547 |
99 | myeloid leukocyte activation (GO:0002274) | 3.17767750 |
100 | negative thymic T cell selection (GO:0045060) | 3.16513501 |
101 | tolerance induction (GO:0002507) | 3.16331307 |
102 | parturition (GO:0007567) | 3.15026192 |
103 | regulation of mast cell activation (GO:0033003) | 3.14193571 |
104 | response to interleukin-15 (GO:0070672) | 3.12274995 |
105 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.11483237 |
106 | negative regulation of interleukin-6 production (GO:0032715) | 3.11443388 |
107 | immunoglobulin mediated immune response (GO:0016064) | 3.11327886 |
108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11194448 |
109 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.09494959 |
110 | cellular response to interleukin-15 (GO:0071350) | 3.07312255 |
111 | regulation of regulated secretory pathway (GO:1903305) | 3.07220088 |
112 | germinal center formation (GO:0002467) | 3.04414171 |
113 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.04359281 |
114 | B cell receptor signaling pathway (GO:0050853) | 3.03886794 |
115 | acrosome assembly (GO:0001675) | 3.02603988 |
116 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.02327695 |
117 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.98066522 |
118 | negative regulation of bone resorption (GO:0045779) | 2.98043882 |
119 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97629360 |
120 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.97588148 |
121 | mast cell activation (GO:0045576) | 2.96815540 |
122 | endothelium development (GO:0003158) | 2.96300784 |
123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.96281015 |
124 | lymphocyte migration (GO:0072676) | 2.95219847 |
125 | positive regulation of mast cell degranulation (GO:0043306) | 2.94689505 |
126 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.94378491 |
127 | positive regulation of lymphocyte migration (GO:2000403) | 2.93121588 |
128 | respiratory burst (GO:0045730) | 2.92663989 |
129 | positive regulation of macrophage differentiation (GO:0045651) | 2.91719674 |
130 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90542076 |
131 | negative T cell selection (GO:0043383) | 2.86297562 |
132 | megakaryocyte development (GO:0035855) | 2.85374229 |
133 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.84503331 |
134 | negative regulation of interleukin-17 production (GO:0032700) | 2.83670267 |
135 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.82844181 |
136 | B cell differentiation (GO:0030183) | 2.79976270 |
137 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.78730762 |
138 | regulation of lymphocyte migration (GO:2000401) | 2.77146162 |
139 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76818399 |
140 | regulation of macrophage differentiation (GO:0045649) | 2.73516561 |
141 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72963955 |
142 | mature B cell differentiation (GO:0002335) | 2.72562305 |
143 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71512683 |
144 | oligosaccharide catabolic process (GO:0009313) | 2.71310876 |
145 | regulation of B cell apoptotic process (GO:0002902) | 2.70169502 |
146 | negative regulation of myotube differentiation (GO:0010832) | 2.69796167 |
147 | neutrophil mediated immunity (GO:0002446) | 2.69138785 |
148 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.68502890 |
149 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.68475545 |
150 | pore complex assembly (GO:0046931) | 2.68167827 |
151 | response to ATP (GO:0033198) | 2.67675771 |
152 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66842065 |
153 | transcription from mitochondrial promoter (GO:0006390) | 2.64734076 |
154 | mannose metabolic process (GO:0006013) | 2.64241504 |
155 | lytic vacuole organization (GO:0080171) | 2.63643656 |
156 | lysosome organization (GO:0007040) | 2.63643656 |
157 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.62005691 |
158 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.61259218 |
159 | amino sugar catabolic process (GO:0046348) | 2.61063024 |
160 | regulation of germinal center formation (GO:0002634) | 2.60245239 |
161 | positive regulation of mast cell activation (GO:0033005) | 2.60012178 |
162 | regulation of leukocyte degranulation (GO:0043300) | 2.58891903 |
163 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.58250297 |
164 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58055102 |
165 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.57427785 |
166 | adenosine receptor signaling pathway (GO:0001973) | 2.56648971 |
167 | G-protein coupled receptor internalization (GO:0002031) | 2.55562788 |
168 | regulation of mononuclear cell migration (GO:0071675) | 2.55346348 |
169 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.53979768 |
170 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.52948436 |
171 | membrane invagination (GO:0010324) | 2.52280678 |
172 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.51148911 |
173 | regulation of monocyte chemotaxis (GO:0090025) | 2.50397950 |
174 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.50018749 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.69267885 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.92114346 |
3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.72198347 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68174297 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.46273543 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.71866804 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.46010616 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32876824 |
9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.19872672 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18925520 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78926289 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78017535 |
13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.69633032 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68877442 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45324449 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44796465 |
17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.39651565 |
18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39612927 |
19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36162312 |
20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26451380 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.22115960 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13860033 |
23 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.13100406 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07604792 |
25 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.05190466 |
26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04119280 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02499522 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97390194 |
29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.92073974 |
30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87280586 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83676824 |
32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79907815 |
33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78596785 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78518351 |
35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77532804 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75539041 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73829222 |
38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.73512098 |
39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72077230 |
40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71637715 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69579843 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69420550 |
43 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68025588 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65034476 |
45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64232998 |
46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63791517 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58500251 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58369292 |
49 | MAF_26560356_Chip-Seq_TH1_Human | 1.55217091 |
50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53750075 |
51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53244062 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45741717 |
53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44821481 |
54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42953063 |
55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42171493 |
56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41952077 |
57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38533928 |
58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38456384 |
59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37809083 |
60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37378420 |
61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37045483 |
62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36094856 |
63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35757249 |
64 | MYC_22102868_ChIP-Seq_BL_Human | 1.35698245 |
65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33115496 |
66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32779814 |
67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30508157 |
68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30387710 |
69 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29643320 |
70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28185126 |
71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28033701 |
72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27562420 |
73 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24956650 |
74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24779730 |
75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24691659 |
76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22388707 |
77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20352640 |
78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19870718 |
79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19234462 |
80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14895042 |
81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14287977 |
82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13621905 |
83 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.13513932 |
84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13156056 |
85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12606520 |
86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12529699 |
87 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11399364 |
88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10606563 |
89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10254932 |
90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09389492 |
91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07920135 |
92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07620289 |
93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06119328 |
94 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05898401 |
95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05708050 |
96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05557454 |
97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05107625 |
98 | MAF_26560356_Chip-Seq_TH2_Human | 1.04847501 |
99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04131304 |
100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03098063 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02465418 |
102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02069329 |
103 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00686181 |
104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00039388 |
105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99975444 |
106 | MYB_26560356_Chip-Seq_TH2_Human | 0.98731100 |
107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98170539 |
108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97794073 |
109 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96589146 |
110 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95174042 |
111 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94710115 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94686587 |
113 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94551170 |
114 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.94369077 |
115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92725713 |
116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92271222 |
117 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91941553 |
118 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.91329673 |
119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91307727 |
120 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89612859 |
121 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89489334 |
122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87952202 |
123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87890114 |
124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87805478 |
125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87777567 |
126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85744304 |
127 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85320109 |
128 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.85199804 |
129 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84807623 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84575491 |
131 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84539907 |
132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84395474 |
133 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84055659 |
134 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83944303 |
135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83506425 |
136 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82051174 |
137 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81693269 |
138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81515777 |
139 | MYB_26560356_Chip-Seq_TH1_Human | 0.81355842 |
140 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.81101811 |
141 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80827428 |
142 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80144980 |
143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79529129 |
144 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79298798 |
145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.78858414 |
146 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.78755219 |
147 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78647473 |
148 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.78188811 |
149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77916325 |
150 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77650211 |
151 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77477061 |
152 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.77030815 |
153 | P300_27268052_Chip-Seq_Bcells_Human | 0.76093660 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 5.30792895 |
2 | MP0000569_abnormal_digit_pigmentation | 4.46752939 |
3 | MP0006082_CNS_inflammation | 3.96282112 |
4 | MP0003191_abnormal_cellular_cholesterol | 3.84046550 |
5 | MP0004147_increased_porphyrin_level | 3.70626033 |
6 | MP0001835_abnormal_antigen_presentation | 3.65553218 |
7 | MP0003172_abnormal_lysosome_physiology | 3.64226332 |
8 | MP0002148_abnormal_hypersensitivity_rea | 2.94833514 |
9 | MP0003303_peritoneal_inflammation | 2.86776838 |
10 | MP0002419_abnormal_innate_immunity | 2.86354333 |
11 | MP0005464_abnormal_platelet_physiology | 2.85309589 |
12 | MP0001545_abnormal_hematopoietic_system | 2.76402880 |
13 | MP0005397_hematopoietic_system_phenotyp | 2.76402880 |
14 | MP0005671_abnormal_response_to | 2.68065844 |
15 | MP0003436_decreased_susceptibility_to | 2.65207638 |
16 | MP0005174_abnormal_tail_pigmentation | 2.63374553 |
17 | MP0005000_abnormal_immune_tolerance | 2.46467609 |
18 | MP0000015_abnormal_ear_pigmentation | 2.43218738 |
19 | MP0003329_amyloid_beta_deposits | 2.41916648 |
20 | MP0003183_abnormal_peptide_metabolism | 2.35732613 |
21 | MP0002452_abnormal_antigen_presenting | 2.34086022 |
22 | MP0001542_abnormal_bone_strength | 2.32539472 |
23 | MP0003690_abnormal_glial_cell | 2.22723588 |
24 | MP0001800_abnormal_humoral_immune | 2.18003477 |
25 | * MP0002723_abnormal_immune_serum | 2.13975323 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 2.12142646 |
27 | MP0002254_reproductive_system_inflammat | 2.11648869 |
28 | MP0004381_abnormal_hair_follicle | 1.97286068 |
29 | MP0005387_immune_system_phenotype | 1.97172913 |
30 | MP0001790_abnormal_immune_system | 1.97172913 |
31 | MP0005025_abnormal_response_to | 1.96794896 |
32 | MP0001986_abnormal_taste_sensitivity | 1.94126218 |
33 | MP0001819_abnormal_immune_cell | 1.90781206 |
34 | MP0002420_abnormal_adaptive_immunity | 1.89769089 |
35 | MP0008004_abnormal_stomach_pH | 1.79388628 |
36 | MP0003724_increased_susceptibility_to | 1.73422277 |
37 | MP0005167_abnormal_blood-brain_barrier | 1.71611353 |
38 | MP0002277_abnormal_respiratory_mucosa | 1.69574159 |
39 | MP0001533_abnormal_skeleton_physiology | 1.68845929 |
40 | MP0001851_eye_inflammation | 1.66923652 |
41 | MP0000371_diluted_coat_color | 1.64006722 |
42 | MP0009785_altered_susceptibility_to | 1.63444972 |
43 | MP0008057_abnormal_DNA_replication | 1.59782262 |
44 | MP0009840_abnormal_foam_cell | 1.56379231 |
45 | MP0005409_darkened_coat_color | 1.53284602 |
46 | MP0002405_respiratory_system_inflammati | 1.52700722 |
47 | MP0003300_gastrointestinal_ulcer | 1.50258558 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.47586844 |
49 | MP0004885_abnormal_endolymph | 1.44602246 |
50 | MP0002998_abnormal_bone_remodeling | 1.35793333 |
51 | MP0005310_abnormal_salivary_gland | 1.34545348 |
52 | MP0002095_abnormal_skin_pigmentation | 1.28757532 |
53 | * MP0001845_abnormal_inflammatory_respons | 1.28159025 |
54 | MP0008469_abnormal_protein_level | 1.27228717 |
55 | MP0000716_abnormal_immune_system | 1.26314903 |
56 | MP0002090_abnormal_vision | 1.26266806 |
57 | MP0005646_abnormal_pituitary_gland | 1.25638353 |
58 | MP0002876_abnormal_thyroid_physiology | 1.25395756 |
59 | MP0001853_heart_inflammation | 1.24371467 |
60 | MP0005257_abnormal_intraocular_pressure | 1.23992247 |
61 | MP0000689_abnormal_spleen_morphology | 1.23735668 |
62 | MP0004947_skin_inflammation | 1.23355841 |
63 | MP0002396_abnormal_hematopoietic_system | 1.22385538 |
64 | MP0000343_altered_response_to | 1.15895068 |
65 | MP0001501_abnormal_sleep_pattern | 1.14144792 |
66 | MP0005171_absent_coat_pigmentation | 1.13369537 |
67 | MP0005165_increased_susceptibility_to | 1.12464023 |
68 | MP0003136_yellow_coat_color | 1.11922960 |
69 | MP0003045_fibrosis | 1.11833102 |
70 | MP0004883_abnormal_blood_vessel | 1.10778253 |
71 | MP0002139_abnormal_hepatobiliary_system | 1.09265346 |
72 | MP0002398_abnormal_bone_marrow | 1.07291793 |
73 | MP0003075_altered_response_to | 1.06590724 |
74 | MP0002166_altered_tumor_susceptibility | 1.03865400 |
75 | MP0003828_pulmonary_edema | 1.03800820 |
76 | MP0000685_abnormal_immune_system | 1.02430944 |
77 | MP0000604_amyloidosis | 0.99691363 |
78 | MP0004510_myositis | 0.99106151 |
79 | MP0005075_abnormal_melanosome_morpholog | 0.98774585 |
80 | MP0002075_abnormal_coat/hair_pigmentati | 0.97494359 |
81 | MP0009333_abnormal_splenocyte_physiolog | 0.96989465 |
82 | MP0002429_abnormal_blood_cell | 0.95727959 |
83 | MP0010155_abnormal_intestine_physiology | 0.94675643 |
84 | MP0003806_abnormal_nucleotide_metabolis | 0.94250907 |
85 | MP0000372_irregular_coat_pigmentation | 0.93555384 |
86 | MP0000920_abnormal_myelination | 0.92069317 |
87 | * MP0002722_abnormal_immune_system | 0.92052931 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.90663093 |
89 | MP0008873_increased_physiological_sensi | 0.89968921 |
90 | MP0002933_joint_inflammation | 0.89712622 |
91 | MP0009379_abnormal_foot_pigmentation | 0.89546737 |
92 | MP0004130_abnormal_muscle_cell | 0.87788065 |
93 | MP0001186_pigmentation_phenotype | 0.87303317 |
94 | MP0005166_decreased_susceptibility_to | 0.87086311 |
95 | MP0002006_tumorigenesis | 0.87085877 |
96 | MP0003448_altered_tumor_morphology | 0.83911972 |
97 | MP0000681_abnormal_thyroid_gland | 0.83120422 |
98 | MP0001764_abnormal_homeostasis | 0.80378820 |
99 | MP0005390_skeleton_phenotype | 0.80132180 |
100 | MP0005164_abnormal_response_to | 0.79828172 |
101 | MP0000249_abnormal_blood_vessel | 0.79329919 |
102 | MP0005084_abnormal_gallbladder_morpholo | 0.78456551 |
103 | MP0005332_abnormal_amino_acid | 0.78344012 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.78232501 |
105 | MP0000703_abnormal_thymus_morphology | 0.76441757 |
106 | MP0000383_abnormal_hair_follicle | 0.75547687 |
107 | MP0001919_abnormal_reproductive_system | 0.75407614 |
108 | MP0002638_abnormal_pupillary_reflex | 0.75168922 |
109 | MP0009278_abnormal_bone_marrow | 0.74954011 |
110 | MP0004808_abnormal_hematopoietic_stem | 0.74469326 |
111 | MP0003453_abnormal_keratinocyte_physiol | 0.74466686 |
112 | MP0002019_abnormal_tumor_incidence | 0.74151447 |
113 | MP0003718_maternal_effect | 0.73341173 |
114 | MP0009764_decreased_sensitivity_to | 0.73228353 |
115 | MP0003943_abnormal_hepatobiliary_system | 0.72830461 |
116 | MP0005197_abnormal_uvea_morphology | 0.72242373 |
117 | MP0003866_abnormal_defecation | 0.71443205 |
118 | MP0005670_abnormal_white_adipose | 0.70631799 |
119 | MP0002928_abnormal_bile_duct | 0.69934462 |
120 | MP0000858_altered_metastatic_potential | 0.69843188 |
121 | MP0003795_abnormal_bone_structure | 0.69255945 |
122 | MP0001873_stomach_inflammation | 0.68881692 |
123 | MP0003878_abnormal_ear_physiology | 0.68211718 |
124 | MP0005377_hearing/vestibular/ear_phenot | 0.68211718 |
125 | MP0009643_abnormal_urine_homeostasis | 0.68123566 |
126 | MP0006072_abnormal_retinal_apoptosis | 0.66817110 |
127 | MP0000367_abnormal_coat/_hair | 0.66108059 |
128 | MP0003566_abnormal_cell_adhesion | 0.65946403 |
129 | MP0010307_abnormal_tumor_latency | 0.65227257 |
130 | MP0009763_increased_sensitivity_to | 0.65189222 |
131 | MP0000230_abnormal_systemic_arterial | 0.64969082 |
132 | MP0001324_abnormal_eye_pigmentation | 0.64852184 |
133 | MP0003763_abnormal_thymus_physiology | 0.64795205 |
134 | MP0003638_abnormal_response/metabolism_ | 0.63621621 |
135 | MP0002060_abnormal_skin_morphology | 0.62552502 |
136 | MP0001188_hyperpigmentation | 0.62541406 |
137 | MP0003252_abnormal_bile_duct | 0.60064184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 6.16310965 |
2 | Cerebral palsy (HP:0100021) | 6.10021295 |
3 | Recurrent abscess formation (HP:0002722) | 5.68429217 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.48457311 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.48457311 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.48457311 |
7 | Vacuolated lymphocytes (HP:0001922) | 5.41944528 |
8 | Increased cerebral lipofuscin (HP:0011813) | 5.36230954 |
9 | Glomerulonephritis (HP:0000099) | 5.29580489 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.23094931 |
11 | Recurrent bacterial skin infections (HP:0005406) | 5.21246040 |
12 | Growth hormone excess (HP:0000845) | 5.20977728 |
13 | Stomach cancer (HP:0012126) | 4.88761942 |
14 | Dysostosis multiplex (HP:0000943) | 4.73742075 |
15 | Retinal atrophy (HP:0001105) | 4.09946685 |
16 | IgG deficiency (HP:0004315) | 4.04836242 |
17 | Eczematoid dermatitis (HP:0000976) | 4.04237909 |
18 | Agammaglobulinemia (HP:0004432) | 4.03928382 |
19 | Disinhibition (HP:0000734) | 4.01589484 |
20 | Axonal loss (HP:0003447) | 3.95803176 |
21 | Abnormality of B cell number (HP:0010975) | 3.94964126 |
22 | Prostate neoplasm (HP:0100787) | 3.92604676 |
23 | Seborrheic dermatitis (HP:0001051) | 3.85865647 |
24 | Global brain atrophy (HP:0002283) | 3.79694104 |
25 | Agnosia (HP:0010524) | 3.79568076 |
26 | B lymphocytopenia (HP:0010976) | 3.78070289 |
27 | Joint swelling (HP:0001386) | 3.76897352 |
28 | Long clavicles (HP:0000890) | 3.61397374 |
29 | Redundant skin (HP:0001582) | 3.59419035 |
30 | Abnormality of T cell physiology (HP:0011840) | 3.54223580 |
31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.49778355 |
32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.49778355 |
33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.49778355 |
34 | Urethral obstruction (HP:0000796) | 3.49570532 |
35 | Mucopolysacchariduria (HP:0008155) | 3.39965473 |
36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.39965473 |
37 | Colitis (HP:0002583) | 3.38934854 |
38 | Complement deficiency (HP:0004431) | 3.34331036 |
39 | Autoimmune thrombocytopenia (HP:0001973) | 3.27643490 |
40 | Glucose intolerance (HP:0000833) | 3.25241849 |
41 | Thick nail (HP:0001805) | 3.25230457 |
42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.24362285 |
43 | Arterial tortuosity (HP:0005116) | 3.18499178 |
44 | Upper motor neuron abnormality (HP:0002127) | 3.17479570 |
45 | Abnormality of T cells (HP:0002843) | 3.16645631 |
46 | Abnormality of macrophages (HP:0004311) | 3.12366287 |
47 | Neurodegeneration (HP:0002180) | 3.12345346 |
48 | Recurrent skin infections (HP:0001581) | 3.11835657 |
49 | Abnormal glucose tolerance (HP:0001952) | 3.09619673 |
50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.00976917 |
51 | Abnormality of male internal genitalia (HP:0000022) | 2.99856523 |
52 | Hypoplasia of the pons (HP:0012110) | 2.95794713 |
53 | Inflammation of the large intestine (HP:0002037) | 2.88008046 |
54 | Granulocytopenia (HP:0001913) | 2.78674722 |
55 | Abnormality of T cell number (HP:0011839) | 2.78003475 |
56 | Gingivitis (HP:0000230) | 2.70984696 |
57 | Vascular tortuosity (HP:0004948) | 2.70582582 |
58 | Nephritis (HP:0000123) | 2.69798324 |
59 | Abnormality of complement system (HP:0005339) | 2.67615020 |
60 | Premature skin wrinkling (HP:0100678) | 2.64648263 |
61 | Stomatitis (HP:0010280) | 2.63815963 |
62 | Abnormality of the pons (HP:0007361) | 2.61164223 |
63 | Hepatosplenomegaly (HP:0001433) | 2.59423894 |
64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58665722 |
65 | Mutism (HP:0002300) | 2.56205277 |
66 | Recurrent fungal infections (HP:0002841) | 2.55847855 |
67 | Periodontitis (HP:0000704) | 2.50818479 |
68 | Ocular albinism (HP:0001107) | 2.50654068 |
69 | Panhypogammaglobulinemia (HP:0003139) | 2.49725355 |
70 | Gastrointestinal inflammation (HP:0004386) | 2.49596059 |
71 | Abnormal platelet function (HP:0011869) | 2.47798205 |
72 | Impaired platelet aggregation (HP:0003540) | 2.47798205 |
73 | Spondylolisthesis (HP:0003302) | 2.45528158 |
74 | Neutropenia (HP:0001875) | 2.44882812 |
75 | Leukocytosis (HP:0001974) | 2.44838716 |
76 | Mediastinal lymphadenopathy (HP:0100721) | 2.43914046 |
77 | Petechiae (HP:0000967) | 2.43286212 |
78 | Pathologic fracture (HP:0002756) | 2.42750748 |
79 | Orchitis (HP:0100796) | 2.42406856 |
80 | Chronic diarrhea (HP:0002028) | 2.42122509 |
81 | Myositis (HP:0100614) | 2.42031118 |
82 | Clumsiness (HP:0002312) | 2.41657716 |
83 | Generalized hypopigmentation of hair (HP:0011358) | 2.40821684 |
84 | Recurrent viral infections (HP:0004429) | 2.40483137 |
85 | Basal ganglia calcification (HP:0002135) | 2.39790058 |
86 | IgM deficiency (HP:0002850) | 2.39769207 |
87 | Progressive visual loss (HP:0000529) | 2.39648412 |
88 | Abnormality of iron homeostasis (HP:0011031) | 2.37668364 |
89 | T lymphocytopenia (HP:0005403) | 2.37648344 |
90 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.37159656 |
91 | Purpura (HP:0000979) | 2.34440891 |
92 | Neurofibrillary tangles (HP:0002185) | 2.34308955 |
93 | Anterior segment dysgenesis (HP:0007700) | 2.34109389 |
94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33031935 |
95 | Obstructive lung disease (HP:0006536) | 2.33031935 |
96 | Optic neuritis (HP:0100653) | 2.31820929 |
97 | Retrobulbar optic neuritis (HP:0100654) | 2.31820929 |
98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29051518 |
99 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29051518 |
100 | Autoimmune hemolytic anemia (HP:0001890) | 2.27654094 |
101 | Increased serum ferritin (HP:0003281) | 2.27352414 |
102 | Intestinal fistula (HP:0100819) | 2.25520846 |
103 | Generalized hypopigmentation (HP:0007513) | 2.24983452 |
104 | Peripheral demyelination (HP:0011096) | 2.23887448 |
105 | Inappropriate behavior (HP:0000719) | 2.22684353 |
106 | Bone pain (HP:0002653) | 2.22154093 |
107 | Hematochezia (HP:0002573) | 2.19913379 |
108 | Epistaxis (HP:0000421) | 2.19420613 |
109 | Intestinal atresia (HP:0011100) | 2.18917065 |
110 | Progressive neurologic deterioration (HP:0002344) | 2.15696096 |
111 | Thoracic kyphosis (HP:0002942) | 2.15493386 |
112 | Myocardial infarction (HP:0001658) | 2.12733135 |
113 | Hyperpituitarism (HP:0010514) | 2.09604206 |
114 | Birth length less than 3rd percentile (HP:0003561) | 2.09595625 |
115 | Neuronal loss in central nervous system (HP:0002529) | 2.08049742 |
116 | Prolonged bleeding time (HP:0003010) | 2.06558835 |
117 | Iris hypopigmentation (HP:0007730) | 2.06337656 |
118 | Premature loss of primary teeth (HP:0006323) | 2.05109374 |
119 | Rectal fistula (HP:0100590) | 2.04876295 |
120 | Rectovaginal fistula (HP:0000143) | 2.04876295 |
121 | Lip pit (HP:0100267) | 2.04763493 |
122 | Abnormality of eosinophils (HP:0001879) | 2.04603930 |
123 | Eosinophilia (HP:0001880) | 2.04320372 |
124 | Osteomyelitis (HP:0002754) | 2.03384494 |
125 | Spontaneous hematomas (HP:0007420) | 2.03193226 |
126 | Submucous cleft hard palate (HP:0000176) | 2.03107459 |
127 | Loss of speech (HP:0002371) | 2.02502113 |
128 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02425541 |
129 | Pustule (HP:0200039) | 2.01821435 |
130 | Meningitis (HP:0001287) | 2.01566024 |
131 | Abnormality of the axillary hair (HP:0100134) | 2.01490435 |
132 | Abnormality of secondary sexual hair (HP:0009888) | 2.01490435 |
133 | Increased IgM level (HP:0003496) | 2.01466006 |
134 | Increased muscle lipid content (HP:0009058) | 2.01397077 |
135 | Pulmonary fibrosis (HP:0002206) | 2.00903660 |
136 | Acne (HP:0001061) | 2.00325115 |
137 | Disproportionate tall stature (HP:0001519) | 2.00266149 |
138 | Cellulitis (HP:0100658) | 1.99865543 |
139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95610911 |
140 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94748397 |
141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94285294 |
142 | Dicarboxylic aciduria (HP:0003215) | 1.94285294 |
143 | Abnormality of the prostate (HP:0008775) | 1.93726113 |
144 | Thyroiditis (HP:0100646) | 1.93059225 |
145 | Recurrent pneumonia (HP:0006532) | 1.92209214 |
146 | Acute lymphatic leukemia (HP:0006721) | 1.92149386 |
147 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.91096133 |
148 | Chest pain (HP:0100749) | 1.90855515 |
149 | Aplastic anemia (HP:0001915) | 1.89133013 |
150 | Personality changes (HP:0000751) | 1.88921031 |
151 | Postural instability (HP:0002172) | 1.87965608 |
152 | J-shaped sella turcica (HP:0002680) | 1.86664097 |
153 | Opisthotonus (HP:0002179) | 1.85110069 |
154 | Impulsivity (HP:0100710) | 1.83755475 |
155 | Hyperammonemia (HP:0001987) | 1.83643580 |
156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83447701 |
157 | Osteolytic defects of the hand bones (HP:0009699) | 1.83447701 |
158 | Thrombocytosis (HP:0001894) | 1.80945849 |
159 | Recurrent bronchitis (HP:0002837) | 1.80334528 |
160 | Abnormality of the periventricular white matter (HP:0002518) | 1.80122878 |
161 | Vasculitis (HP:0002633) | 1.80122400 |
162 | Thickened calvaria (HP:0002684) | 1.80020308 |
163 | Abnormality of the columella (HP:0009929) | 1.79583887 |
164 | Spastic paraparesis (HP:0002313) | 1.79225331 |
165 | Clubbing of toes (HP:0100760) | 1.78198492 |
166 | IgA deficiency (HP:0002720) | 1.78191389 |
167 | Carpal bone hypoplasia (HP:0001498) | 1.77375026 |
168 | Cutaneous melanoma (HP:0012056) | 1.75436479 |
169 | Rhabdomyolysis (HP:0003201) | 1.73867234 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 5.75841165 |
2 | RIPK1 | 4.89283051 |
3 | BLK | 3.44944044 |
4 | GRK7 | 3.41189056 |
5 | MAP2K2 | 3.07049818 |
6 | PIK3CA | 3.05190831 |
7 | IRAK3 | 2.96185722 |
8 | GRK6 | 2.95899474 |
9 | RIPK4 | 2.76467574 |
10 | IRAK4 | 2.72327216 |
11 | MAPK15 | 2.43985985 |
12 | TYK2 | 2.40057654 |
13 | KIT | 2.13077201 |
14 | CSF1R | 2.11059075 |
15 | BCKDK | 2.08693246 |
16 | MAP3K14 | 2.06388325 |
17 | MAP2K3 | 1.98459195 |
18 | IKBKB | 1.91416197 |
19 | TXK | 1.87970615 |
20 | TBK1 | 1.78365772 |
21 | CDK3 | 1.78141320 |
22 | TLK1 | 1.72686322 |
23 | TNIK | 1.71111262 |
24 | ZAP70 | 1.68358946 |
25 | FES | 1.65676091 |
26 | MAP3K6 | 1.60731152 |
27 | CAMK1D | 1.57855914 |
28 | TAOK3 | 1.54623581 |
29 | EIF2AK2 | 1.53446951 |
30 | MAP4K1 | 1.49224491 |
31 | NEK9 | 1.45750518 |
32 | KDR | 1.40273208 |
33 | TRPM7 | 1.37517936 |
34 | CAMK1G | 1.35526793 |
35 | YES1 | 1.34705726 |
36 | ITK | 1.33954073 |
37 | IKBKE | 1.33845625 |
38 | LYN | 1.32219267 |
39 | BMPR2 | 1.31488903 |
40 | HCK | 1.31381821 |
41 | MAPKAPK5 | 1.29996556 |
42 | MAPK7 | 1.28068049 |
43 | INSRR | 1.27056131 |
44 | JAK1 | 1.25838815 |
45 | MAPK12 | 1.24004083 |
46 | STK10 | 1.23641569 |
47 | CLK1 | 1.23015886 |
48 | MAP3K7 | 1.21291915 |
49 | SYK | 1.15732859 |
50 | TESK2 | 1.13561066 |
51 | DAPK2 | 1.13536355 |
52 | TEC | 1.13085010 |
53 | LCK | 1.11405670 |
54 | SRPK1 | 1.08819027 |
55 | MAPKAPK3 | 1.05991897 |
56 | EIF2AK3 | 1.05429635 |
57 | MOS | 1.04203904 |
58 | MAP3K11 | 1.03626249 |
59 | BMPR1B | 1.00726903 |
60 | CSK | 1.00365468 |
61 | MAP3K13 | 1.00128119 |
62 | SCYL2 | 0.99484818 |
63 | MAP4K2 | 0.97870570 |
64 | NME2 | 0.96891355 |
65 | PINK1 | 0.96595158 |
66 | MATK | 0.95177240 |
67 | PDK2 | 0.94896534 |
68 | PLK4 | 0.90316481 |
69 | BRD4 | 0.89176831 |
70 | PIM1 | 0.89053944 |
71 | PKN1 | 0.87616463 |
72 | MAP3K3 | 0.87321497 |
73 | BTK | 0.86891489 |
74 | CAMKK2 | 0.85430018 |
75 | PIK3CG | 0.83364237 |
76 | EEF2K | 0.83296176 |
77 | SIK2 | 0.81010378 |
78 | CHUK | 0.79850137 |
79 | RPS6KA6 | 0.79792226 |
80 | RPS6KC1 | 0.78956612 |
81 | RPS6KL1 | 0.78956612 |
82 | ADRBK2 | 0.78441902 |
83 | ARAF | 0.78306804 |
84 | MAP2K1 | 0.76744753 |
85 | MAPK4 | 0.75476011 |
86 | RPS6KA4 | 0.72967181 |
87 | BUB1 | 0.72735195 |
88 | SGK2 | 0.71513502 |
89 | FLT3 | 0.68182141 |
90 | IGF1R | 0.68062877 |
91 | JAK2 | 0.67982212 |
92 | MAPKAPK2 | 0.61133440 |
93 | IRAK1 | 0.59638677 |
94 | MKNK1 | 0.59629380 |
95 | ERBB2 | 0.57747988 |
96 | GRK5 | 0.56213371 |
97 | MST4 | 0.55930879 |
98 | PASK | 0.54171348 |
99 | SGK3 | 0.53609241 |
100 | CDK6 | 0.53213319 |
101 | CASK | 0.52616748 |
102 | EGFR | 0.52134124 |
103 | TNK2 | 0.51802810 |
104 | FGR | 0.50812647 |
105 | PRKAA2 | 0.50013641 |
106 | JAK3 | 0.49465992 |
107 | CCNB1 | 0.49207319 |
108 | RPS6KA5 | 0.49008356 |
109 | NEK6 | 0.48628439 |
110 | IRAK2 | 0.47019079 |
111 | RPS6KA2 | 0.45536832 |
112 | ERBB3 | 0.45387294 |
113 | NLK | 0.43723982 |
114 | ZAK | 0.42964140 |
115 | RET | 0.42546995 |
116 | MAP3K9 | 0.41473942 |
117 | MAPK3 | 0.40600104 |
118 | PIM2 | 0.39266209 |
119 | PRKCQ | 0.38629680 |
120 | GSK3A | 0.38352993 |
121 | PRKCD | 0.37002302 |
122 | PDK1 | 0.36815938 |
123 | MAP3K1 | 0.36627628 |
124 | CAMK4 | 0.35377558 |
125 | NUAK1 | 0.34797252 |
126 | VRK1 | 0.34681743 |
127 | FYN | 0.33413258 |
128 | GRK1 | 0.33252213 |
129 | RPS6KA1 | 0.33193536 |
130 | BRAF | 0.32241614 |
131 | CAMK1 | 0.32205052 |
132 | ABL1 | 0.31953017 |
133 | PRKG1 | 0.31612536 |
134 | CDK8 | 0.31302936 |
135 | TIE1 | 0.30416446 |
136 | HIPK2 | 0.29138334 |
137 | INSR | 0.29080465 |
138 | ERN1 | 0.28423550 |
139 | CDK9 | 0.27866128 |
140 | CSNK2A1 | 0.27328419 |
141 | PAK4 | 0.27111404 |
142 | ABL2 | 0.25695183 |
143 | MAP2K6 | 0.25401053 |
144 | PBK | 0.24137199 |
145 | RPS6KB2 | 0.23994567 |
146 | RAF1 | 0.21446305 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.08315452 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.04570140 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.72212298 |
4 | Lysosome_Homo sapiens_hsa04142 | 3.21922229 |
5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.92790443 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64706891 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30944384 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25878170 |
9 | DNA replication_Homo sapiens_hsa03030 | 2.16475177 |
10 | Pertussis_Homo sapiens_hsa05133 | 1.96344061 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93297239 |
12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89517121 |
13 | Tuberculosis_Homo sapiens_hsa05152 | 1.79782177 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 1.77419101 |
15 | Mismatch repair_Homo sapiens_hsa03430 | 1.75830200 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75304769 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66398348 |
18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62277237 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62220700 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60880775 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58982521 |
22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.53160041 |
23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45367138 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.44445576 |
25 | Measles_Homo sapiens_hsa05162 | 1.43437521 |
26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35682713 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.31799347 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29760447 |
29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29707695 |
30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29061847 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24435692 |
32 | Influenza A_Homo sapiens_hsa05164 | 1.24348841 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22068673 |
34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18488183 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16276411 |
36 | Malaria_Homo sapiens_hsa05144 | 1.16192866 |
37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14473665 |
38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14410455 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13783031 |
40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12929637 |
41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11651487 |
42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10735628 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08842484 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07596390 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07244084 |
46 | Legionellosis_Homo sapiens_hsa05134 | 1.03624247 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.03480278 |
48 | ABC transporters_Homo sapiens_hsa02010 | 0.99087838 |
49 | Allograft rejection_Homo sapiens_hsa05330 | 0.97081107 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.95597745 |
51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94814012 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.93289567 |
53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91349207 |
54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87721835 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83370244 |
56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81927084 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81912516 |
58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80889252 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80230518 |
60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79513480 |
61 | Asthma_Homo sapiens_hsa05310 | 0.78878578 |
62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78054962 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76927678 |
64 | Hepatitis C_Homo sapiens_hsa05160 | 0.76665813 |
65 | Peroxisome_Homo sapiens_hsa04146 | 0.75591327 |
66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75220565 |
67 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72812120 |
68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72093013 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70310724 |
70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69396321 |
71 | Endocytosis_Homo sapiens_hsa04144 | 0.68280508 |
72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67778347 |
73 | Purine metabolism_Homo sapiens_hsa00230 | 0.67182497 |
74 | Hepatitis B_Homo sapiens_hsa05161 | 0.66569427 |
75 | Spliceosome_Homo sapiens_hsa03040 | 0.66470054 |
76 | Prion diseases_Homo sapiens_hsa05020 | 0.64177457 |
77 | Ribosome_Homo sapiens_hsa03010 | 0.64134988 |
78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62550484 |
79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62367723 |
80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61985282 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61844763 |
82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61740337 |
83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60708995 |
84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58581957 |
85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56990666 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56038632 |
87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55955163 |
88 | Shigellosis_Homo sapiens_hsa05131 | 0.54912787 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.52582584 |
90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52556927 |
91 | RNA degradation_Homo sapiens_hsa03018 | 0.52298410 |
92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48429130 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46345124 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45337226 |
95 | Renin secretion_Homo sapiens_hsa04924 | 0.44740710 |
96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44700707 |
97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44042132 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42634632 |
99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42509033 |
100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41831442 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41090400 |
102 | Morphine addiction_Homo sapiens_hsa05032 | 0.40069404 |
103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39831046 |
104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39789283 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39763112 |
106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39264512 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39036391 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38257755 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37854878 |
110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37350663 |
111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36257439 |
112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35463076 |
113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35295839 |
114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35283928 |
115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35009603 |
116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33441889 |
117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33073485 |
118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31867935 |
119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31316471 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30825204 |
121 | Amoebiasis_Homo sapiens_hsa05146 | 0.30666070 |
122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29010432 |
123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28747291 |
124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27518369 |
125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26948346 |
126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26723847 |
127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26178872 |
128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25702942 |
129 | Prostate cancer_Homo sapiens_hsa05215 | 0.25217964 |
130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25064811 |
131 | Salivary secretion_Homo sapiens_hsa04970 | 0.25053991 |
132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24940318 |
133 | RNA transport_Homo sapiens_hsa03013 | 0.24083428 |